Dupilumab

Dupilumab is a human monoclonal antibody directed against interleukin 4 receptor alpha (IL4RA). Dupilumab is being used in the treatment of moderate-to-severe atopic dermatitis and for asthma.

What can Sanquin do for you?

Measure drug levels of free drug in the serum using an validated ELISA.
Measure the immunogenicity of dupilumab.
Provide assay reagents or co-develop novel testing strategies.
Folllowing ISO, FDA/EMA, RUO guidelines.

Enquire about our drug level and ADA assays by emailing us at [email protected].

Last edited on: 23 November 2022